878671-93-3

Basic information

• Product Name: 1-Cyclopropyl-4-nitronaphthalene
• Synonyms: 1-Cyclopropyl-4-nitronaphthalene
• CAS NO: 878671-93-3
• Molecular Formula: C₁₃H₁₁NO₂
• Molecular Weight: 213.23194
• Mol File: 878671-93-3.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 375.2±21.0 °C(Predicted)
• Appearance: /
• Density: 1.305±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1-Cyclopropyl-4-nitronaphthalene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Cyclopropyl-4-nitronaphthalene(878671-93-3)
• EPA Substance Registry System: 1-Cyclopropyl-4-nitronaphthalene(878671-93-3)

Safety Data

• Hazardous Substances Data: 878671-93-3(Hazardous Substances Data)

Usage

General Description

1-Cyclopropyl-4-nitronaphthalene is a chemical compound that consists of a naphthalene ring with a cyclopropyl group at position 1 and a nitro group at position 4. It is a yellowish crystalline solid that is insoluble in water but soluble in organic solvents. 1-Cyclopropyl-4-nitronaphthalene is mainly used in the production of pharmaceuticals and agrochemicals, as well as in the synthesis of other organic compounds. It can also be used as a starting material in the laboratory synthesis of various derivatives with potential biological and pharmacological activities. Additionally, 1-Cyclopropyl-4-nitronaphthalene is considered to be a hazardous chemical and should be handled with care and proper safety precautions.

Upstream product

• 25033-19-6 1-cyclopropyl-naphthalene 

Downstream Products

• 878671-94-4 1-amino-4-cyclopropylnaphthalene 
• 1533519-92-4 1-amino-4-cyclopropylnaphthalene hydrochloride 
• 1533519-86-6 N-(4-cyclopropylnaphthalen-1-yl)-2-formylhydrazine-1-thiocarboxamide 
• 1533519-84-4 4-(4-cyclopropylnaphthalen-1-yl)-4Η-1,2,4-triazole-3-thiol 
• 1533519-85-5 2-((4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-3-yl)thio)acetic acid methyl ester 
• 878672-00-5 (-)-2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid 
• 878672-00-5 (+)-2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid 
• 878672-00-5 2-{[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid 
• 878671-98-8 2-((5-amino-4-(4-cyclopropyl-naphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid methyl ester 

Relevant articles and documents

Lesinurad analogue and its preparation method and medical use

The invention relates to a lesinurad analog as shown in the general formula (I), its preparation method, a pharmaceutical composition containing the derivative and an application of the pharmaceutical composition used as a therapeutic agent, especially as a medicine for treating hyperuricemia and gout, wherein definition of each substituent group in the general formula (I) is as the same as definition in the specification.

Optically pure thioacetic compound

The invention belongs to the field of pharmacy and relates to an optically pure thioacetic compound and application thereof to medicine. The optically pure thioacetic compound comprises levorotatory 2-(5-bromo-4-(4-cyclopropyl-naphthalene-1-base)-4H-1,2,4-triazole-3-based sulfenyl) acetic acid and dextral 2-(5-bromo-4-(4-cyclopropyl-naphthalene-1-base)-4H-1,2,4-triazole-3-based sulfenyl) acetic acid.

POLYMORPHIC, CRYSTALLINE AND MESOPHASE FORMS OF SODIUM 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETATE, AND USES THEREOF

Crystalline polymorphs and solid mesophase forms of sodium 2-(5-bromo-4- (4-cyclopropylnaphthalen-l-yl)-4H-l,2,4-triazol-3-ylthio)acetate are described. In addition, pharmaceutical compositions and uses of such compositions for the treatment of a variety of diseases and conditions are provided.